Articles
-
1 week ago |
curetoday.com | Virginia Kaklamani |Megan Kruse
Author(s):,Panelists discuss balancing clinical trial data with real-world patient factors when choosing between treatment options, emphasizing the importance of quality of life alongside cancer control in the second-line setting.
-
1 week ago |
curetoday.com | Virginia Kaklamani |Megan Kruse
Author(s):,Panelists discuss how to approach second-line therapy decisions for patients with metastatic breast cancer, emphasizing the importance of biomarker testing, including ESR1 mutations, and considering patient-specific factors.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →